Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (305)	12/19/1998 6:08:00 PM
From: Larry Liebman	Read Replies (1) \| Respond to of 1073

If I were AMGN, looking at my cap of $20 billion, thinking about my pipeline, I'd issue 10% of my shares, raise $2 billion, and own the 3rd tier universe. You could swallow ONXX, LKST, ARIA, MCDE, ABSC, OSIP, GENE, ALXN, NPSP, SIBI, ARQL... Actually, they might only need 5%!!! I would bet that '99 will be a solid biotech year, with significant consolidation, with large cap biotechs(e.g., BGEN/AMGN/GENZ/GNE/MEDI/BCHE/IMNX) picking up "bargains".

To: scaram(o)uche who wrote (305)	12/22/1998 12:36:00 AM
From: Miljenko Zuanic	Read Replies (2) \| Respond to of 1073

<<Do they still own 25% of Modex? Does anyone know if Modex is doing anything beyond encapsulation stuff?>> Yes, they still own 25% of Modex. They did scale back license agreement with Modex (in October 97) regardless that new agreement include two new target for encapsulated technology: Factor VIII and IX for hemophilia A and B (previous ones are for diabetes, obesity, and anemia). What is Modex doing today I do not have any clue. Recently CTII adapted shareholder right plan, I guess as protection from hostile bayer, or to screw small investor like me. Does this new technology license from Scripts suggest/indicate path by which they intend to solve problem with allogenic steam cells implant(immunology and differentiation/factor)? Miljenko